Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

PRP injections may improve hair thickness and density in female hair loss patients.

Peps help Arabidopsis plants grow more root hairs by affecting specific genes and calcium signaling.

Primary hypothyroidism can mimic pituitary failure but improves with hormone therapy.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Two patients with stubborn hair loss grew hair after PDRN injections.

Topical peptides may offer safer, effective pain relief and healing for wounds.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Thyroid receptor β can help develop new drugs to treat hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

p2y5, now called LPA6, is a receptor important for human hair growth.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

A new peptide, DualPep-ALO, may help hair growth by reducing inflammation and boosting growth factors.

PAR-1 may play a role in hair growth regulation in human hair follicles.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

TAK-279 effectively reduces psoriasis symptoms and is safe.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Self-assembling peptide hydrogels effectively deliver drugs locally, enhancing treatment and reducing side effects.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

CGRP-IR axons may help maintain and renew tissues.